| Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
|---|
| 06/30/2005 | US20050143452 Serotonin receptors agonists; central nervous system disorders; schizophrenia, anxiety disorders, bipolar disorders, obesity; 1-[7-(2,3-dimethylphenyl)-2,3-dihydro-1-benzofuran-2-yl]methanamine; side effect reduction; antipsychotic |
| 06/30/2005 | US20050143426 Osteoporosis, bone disorders, or diseases associated with excessive secretion of PTH, such as hyperparathyroidism; reduce or inhibit parathyroid hormone (PTH) secretion |
| 06/30/2005 | US20050143422 N-({4'-[(1-benzofuran-2-ylcarbonyl)amino]-1,1'-biphenyl-4-yl}sulfonyl)glycine; metalloproteinase inhibitors; arthritis, macular degeneration, graft versus host disease, cancer, osteoarthritis |
| 06/30/2005 | US20050142155 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 06/30/2005 | US20050139814 Benzofuran and benzothiophene derivatives useful in the treatmint of hyper-proliferative disorders |
| 06/30/2005 | CA2854783A1 Prostaglandin synthesis |
| 06/30/2005 | CA2549660A1 Cyclopropane compounds and pharmaceutical use thereof |
| 06/30/2005 | CA2549598A1 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof |
| 06/30/2005 | CA2549458A1 A process for the liquefaction of lignocellulosic material |
| 06/30/2005 | CA2549056A1 Prostaglandin synthesis |
| 06/30/2005 | CA2545506A1 Novel benzofuran derivatives, which can be used in prophylaxis or treatment of 5-ht6 receptor-related disorder |
| 06/30/2005 | CA2545294A1 Tetronic and tetramic acids as inhibitors of beta-secrease |
| 06/29/2005 | EP1548014A1 Ultraviolet-permeable fluoropolymers and pellicles made by using the same |
| 06/29/2005 | EP1547996A1 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein |
| 06/29/2005 | EP1546116A1 Vanilloid receptor ligands and their use in treatments |
| 06/29/2005 | EP1546089A2 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 06/29/2005 | EP1546087A1 3-amino-2-hrydroxyalkanoic acids and their prodrugs |
| 06/29/2005 | EP1546077A2 Chiral diols, their manufacture and ligands and catalysts derived therefrom |
| 06/29/2005 | EP1545501A2 Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma |
| 06/29/2005 | CN1633426A 1, 3-dihydroxy benzene derivatives and coloring agent containing the same |
| 06/29/2005 | CN1633425A Process for the preparation of ascorbic acid |
| 06/29/2005 | CN1633410A Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases(ptps) |
| 06/29/2005 | CN1633296A Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/29/2005 | CN1631885A Compound with nematocidal activity and its application |
| 06/29/2005 | CN1631879A Substituted phenyl keto enols as pesticides and herbicides |
| 06/29/2005 | CN1631878A C2 phenyl-substituted cyclic keto-enols used as pesticides and herbicides |
| 06/29/2005 | CN1631864A Method for optically and selectively epoxidizing alkenone compound |
| 06/29/2005 | CN1631363A Preventives/remedies for arteriosclerosis |
| 06/29/2005 | CN1208331C Di (trialkylbenzotri acid anhydride) derivative for optical communication |
| 06/29/2005 | CN1208330C Method for extracting red-rooted salvia root anti-peptic ulcer effective part |
| 06/29/2005 | CN1208329C Aniline derivatives |
| 06/29/2005 | CN1208319C 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 06/29/2005 | CN1208300C Method of gas phase catalytic oxidation to give maleic acid anhydride |
| 06/28/2005 | US6911548 Method for the preparation of 5-cyanophthalide |
| 06/28/2005 | US6911546 Catalytic depolymerization of polymers containing electrophilic linkages using nucleophilic reagents |
| 06/28/2005 | US6911469 For therapy of disease treatable based on a blood sugar level-depressing activity or a disease treatable based on a cGMP-PDE inhibiting activity, smooth muscle relaxing activity, bronchodilating activity, vasodilating activity |
| 06/28/2005 | US6911461 For treating epilepsy, epileptogenesis, seizure disorders, convulsions, bipolar disorders, mania, depression, anxiety, migraine, neuralgia, chronic pain, neuropathic pain, cerebral ischemia, cardiac arrhythmia, myotonia, cocaine abuse |
| 06/28/2005 | CA2168097C Substituted 2-aminotetralins |
| 06/23/2005 | WO2005056519A1 Alpha-ketoamide derivative, and production method and use thereof |
| 06/23/2005 | WO2005056516A1 Biphenyl derivatives useful as ligands that activate the rar receptors, process for preparing them and use thereof in human medicine and in cosmetics |
| 06/23/2005 | WO2005056510A2 Novel ligands that are activators of the rar receptors, use in human medicine and in cosmetics |
| 06/23/2005 | WO2005055959A2 Bulky monomers leading to resins exhibiting low polymerization shrinkage |
| 06/23/2005 | WO2005055940A2 Novel m3 muscarinic acetylcholine receptor antagonists |
| 06/23/2005 | WO2005055935A2 Cationic substituted benzofurans as antimicrobial agents |
| 06/23/2005 | WO2005055715A2 Insecticidal n-(heteroarylalkyl) alkanediamine derivatives |
| 06/23/2005 | WO2005033056A3 Triphenylethylene compounds as selective estrogen receptor modulators |
| 06/23/2005 | US20050137402 Process for preparing alkynyl-substituted aromatic and heterocyclic compounds |
| 06/23/2005 | US20050137271 Pretreatment of oxygen gas with heat exchanger; uniformity gas flow |
| 06/23/2005 | US20050137255 Novel crystal form that is stable, water soluble, and nonhygroscopic at a relative humidity less than 70% |
| 06/23/2005 | US20050137254 Formed during fermentation by microorganism Aspergillus flavipes; for the treatment and/or prophylaxis of bacterial infectious diseases or mycoses |
| 06/23/2005 | US20050137234 Histone deacetylase inhibitors |
| 06/23/2005 | US20050137207 Inhibitor of prenylprotein tranferase for cancer and tumor treatment |
| 06/23/2005 | US20050137192 Use of compounds such as 4-bromo-9a-butyl-8-chloro-6-fluoro-7-hydroxy-1,2,9,9a-tetrahydro-3H-fluoren-3-one to treat depression |
| 06/23/2005 | US20050137191 Nitrate esters and their use for mitigating cellular damage |
| 06/23/2005 | US20050136136 Method for isolating terpene trilactones (ginkgolides, bilobadide) from leaves and pharmaceutical powders of ginkgo biloba |
| 06/23/2005 | US20050135737 Optical interleaver |
| 06/23/2005 | DE102004053279A1 Benzofuran and benzothiophene derivatives, useful as components of liquid crystal media for electro-optical display devices are new |
| 06/23/2005 | CA2549736A1 Cationic substituted benzofurans as antimicrobial agents |
| 06/23/2005 | CA2549272A1 Novel m3 muscarinic acetylcholine receptor antagonists |
| 06/23/2005 | CA2545112A1 Novel ligands that are activators of the rar receptors, use in human medicine and in cosmetics |
| 06/22/2005 | EP1543148A1 Method and probe for identifying bacterial virulence modifying agents, agents thus identified, and their use |
| 06/22/2005 | EP1542992A2 Process for preparing quinazoline rho-kinase inhibitors and intermediates thereof |
| 06/22/2005 | EP1542967A1 Amide and sulfonamide ligands for the estrogen receptor |
| 06/22/2005 | EP1542966A1 Aromatic liver x-receptor modulators |
| 06/22/2005 | EP1542948A2 Novel biphenyl and biphenyl-like cannabinoids |
| 06/22/2005 | EP1542692A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain |
| 06/22/2005 | EP1320523B1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases |
| 06/22/2005 | EP1100763B1 Diketoacid-derivatives as inhibitors of polymerases |
| 06/22/2005 | EP1082127B1 Succinamide inhibitors of interleukin-1beta converting enzyme |
| 06/22/2005 | CN1630635A Amino alcohol derivatives or phosphonic acid derivatives and pharmaceutical compositions containing these |
| 06/22/2005 | CN1630632A Aromatic amino acid derivates and medicinal compositions |
| 06/22/2005 | CN1630555A Hydroxylation of beta-dicarbonyls with zirconium catalysts |
| 06/22/2005 | CN1629153A 西酞普兰中间体晶体碱 Citalopram intermediate crystal base |
| 06/22/2005 | CN1629152A Use of 1-methyl-4-isopropyl-bicyclo[2, 2, 2] octane-2, 3-diacid anhydride |
| 06/22/2005 | CN1629151A Process waste water discharging free method for the production of furfural |
| 06/22/2005 | CN1629139A Dialkyl and diaryl tetrasubstituted heterocyclic compounds, preparing process and use thereof |
| 06/22/2005 | CN1628773A Botanical originated nim oil sperm killing formulation |
| 06/22/2005 | CN1207289C Metalloproteinase inhibitors, pharmaceutical compositions containing the same and their pharmaceutical uses, and methods and intermediates useful for their preparation |
| 06/22/2005 | CN1207281C Trifluoromethyl-substd. spirocyclic ketoenols |
| 06/22/2005 | CN1207261C Fluorine-contained polybasic carboxylic acid compound synthesis method and use thereof |
| 06/21/2005 | US6909016 Production of butane tetracarboxylic acid derivative by means of coupled electrosynthesis |
| 06/21/2005 | US6909013 Process for producing cyclopropanecarboxylates |
| 06/21/2005 | US6908935 Calcium receptor modulating agents |
| 06/21/2005 | CA2180010C 7-¬carboxyalkyl or alkenyl|-6-¬alkyl or alkenyl| 3-oxo-2,4-dioxobicyclo-¬3.2.1| octane and derivatives thereof |
| 06/21/2005 | CA2110579C High productivity process for the production of maleic anhydride |
| 06/16/2005 | WO2005054336A1 Pellicle and novel fluorinated polymer |
| 06/16/2005 | WO2005054251A1 New cartharidic amine, demethyl cartharidic amine derivatives and their medicinal use |
| 06/16/2005 | WO2005054226A1 Benzofurans and benzothiophenes |
| 06/16/2005 | WO2005054225A1 Antidiabetic compounds comprising benzofuran and benzothiophene derivatives |
| 06/16/2005 | WO2005054221A1 Gsk-3 inhibitors isolated from marine organisms |
| 06/16/2005 | WO2005054204A2 Pharmaceutical compounds that regenerate in vivo |
| 06/16/2005 | WO2005054170A1 Remedy |
| 06/16/2005 | WO2005012278A3 Process for purifying citalopram using polybasic acids |
| 06/16/2005 | US20050131239 Preparation of aryl-substituted butenolides using mucohalic acids |
| 06/16/2005 | US20050131042 HIV protease inhibiting compounds |
| 06/16/2005 | US20050131032 (Oxime)carbamoyl fatty acid amide hydrolase inhibitors |
| 06/16/2005 | US20050131022 Such as 5-nitro-furan-2-carboxylic acid (2-piperidin-1-yl-phenyl)-amide; diabetes, angiogenesis, psoriasis, restenosis, schizophrenia, rheumatoid arthritis, cardiovascular disease, cancer |
| 06/16/2005 | US20050131018 Acetylene derivatives as inhibitors of histone deacetylase |
| 06/16/2005 | US20050130973 3-Methyl-2-[4'-(pyridin-3-ylmethoxymethyl)-biphenyl-4-sulfonylamino]-butyric acid; metalloproteinase inhibitors; arthritis, macular degeneration, graft versus host disease, cancer, osteoarthritis |
| 06/16/2005 | US20050130959 Selective in presence of at least one other cathepsin isozyme; such as (3-cyclopentyl-{[5-(3-fluoro-phenyl)-furan-2-carbonyl]-amino}-propionylamino)-4-oxo-butyric acid |